About us
A biotechnology company developing gene therapies for neurodegenerative disease.
Our vision
We’re redefining the future of neurodegenerative disease treatment — to restore hope where no cures exist.
Who we are
Celosia Therapeutics is a biotechnology company developing precision gene therapies for neurodegenerative diseases, including ALS and FTD.
Built on decades of neuroscience research, our work focuses on targeting the underlying genetic and cellular drivers of disease, with the goal of modifying the neuronal microenvironment to halt, reverse and defeat neurodegenerative disease.
Meet our team
Dr Kathryn Sunn
PhD, CEO
Yazi Diana Ke
PhD, Inventor / Chief Operating Officer
Professor Lars M Ittner
MD, Founder / Chief Scientific and
Medical Officer